Bio Medica Lab

Why is Bio Medica Lab falling/rising?

As of 12-Jul, Bio Medica Laboratories Ltd's stock price is at 130.00, showing a slight increase today but a 7.14% decline over the past week. The stock is trading below key moving averages and experiencing reduced investor participation, indicating bearish trends.

As of 12-Jul, Bio Medica Laboratories Ltd's stock price is currently at 130.00, reflecting a slight increase of 0.35 (0.27%). Despite this minor rise, the stock has shown a negative performance over the past week, with a decline of 7.14%, while the benchmark Sensex has only decreased by 0.26%. Over the past month, the stock has gained 4.17%, which is slightly lower than the Sensex's increase of 4.27%.<BR><BR>Today's performance indicates that the stock is trading lower than its moving averages across various time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This suggests a bearish trend in the stock's price movement. Additionally, there has been a notable decrease in investor participation, with a delivery volume of 1.43 lacs on 09 July, which is down by 21.94% compared to the 5-day average. This decline in trading activity may indicate reduced investor interest or confidence in the stock.<BR><BR>Overall, while there is a small uptick in the stock price today, the broader context of declining performance over the past week, lower trading volumes, and trading below key moving averages suggests that the stock is facing downward pressure.

Which are the latest news on Bio Medica Lab?

What does Bio Medica Lab do?

Bio Medica Laboratories Ltd is a Micro Cap company in the Pharmaceuticals & Biotechnology sector, incorporated in 2015. It has a market cap of INR 167 Cr, with a P/E ratio of 16.00 and a return on equity of 66.45%.

Overview: <BR>Bio Medica Laboratories Ltd operates in the Pharmaceuticals & Biotechnology industry and is classified as a Micro Cap company.<BR><BR>History: <BR>Bio Medica Laboratories Limited was originally incorporated as a private limited company under the name "Bio Medica Laboratories Private Limited" on August 14, 2015, by the Registrar of Companies in Gwalior. There are no recent updates regarding sales and profit data.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: N/A <BR>Most recent Net Profit: N/A <BR>Market-cap value: INR 167 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 16.00 <BR>Industry P/E: 34 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 1.02 <BR>Return on Equity: 66.45% <BR>Price-to-Book: 11.17 <BR><BR>Contact Details: <BR>Registrar Address: Not available. <BR>Phone: N/A <BR>Email: N/A <BR>Website: N/A

How big is Bio Medica Lab?

As of 10th June, Bio Medica Laboratories Ltd has a market capitalization of 167.00 Cr, classifying it as a Micro Cap company. There is no valid financial data available for Net Sales and Net Profit for the latest four quarters.

As of 10th June, <BR><BR>Market Cap: Bio Medica Laboratories Ltd has a market capitalization of 167.00 Cr, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: There is no valid financial data available for Net Sales and Net Profit for the latest four quarters.<BR><BR>Balance Sheet Snapshot: The reporting period is March 2025, with Shareholder's Funds amounting to 14.73 Cr and Total Assets valued at 38.90 Cr.

Who are the peers of the Bio Medica Lab?

Bio Medica Lab's peers include Quest Laboratories, Natural Capsules, Panch. Organics, Auro Labs, Achyut Healthcare, Coral Labs, Kimia Biosciences, Oxygenta Pharma, and Parnax Lab, with varying management risks and growth ratings. Quest Laboratories shows the highest 1-year return at 7.07%, while Natural Capsules has the lowest at -34.68%.

Peers: The peers of Bio Medica Lab are Quest Laborato., Natural Capsules, Panch.Organics, Auro Labs., Achyut Healthcar, Coral Labs., Kimia Bioscien., Oxygenta Pharma, and Parnax Lab.<BR><BR>Quality Snapshot: Excellent management risk is observed at Quest Laborato. and Parnax Lab, while Average management risk is found at Panch.Organics and Auro Labs., and Below Average management risk is present at Natural Capsules, Achyut Healthcar, Coral Labs., Kimia Bioscien., and Oxygenta Pharma. Growth is rated as Good at Quest Laborato. and Parnax Lab, Average at Achyut Healthcar, and Below Average at Natural Capsules, Panch.Organics, Auro Labs., Coral Labs., Kimia Bioscien., and Oxygenta Pharma. Excellent capital structure is noted at Quest Laborato., Panch.Organics, Coral Labs., and Parnax Lab, while Below Average capital structure is seen at Natural Capsules, Auro Labs., Achyut Healthcar, and Kimia Bioscien., and Oxygenta Pharma does not qualify.<BR><BR>Return Snapshot: Quest Laborato. has the highest 1-year return at 7.07%, while Natural Capsules has the lowest at -34.68%, with Bio Medica Lab's 1-year return being not available for comparison. Additionally, Natural Capsules and Oxygenta Pharma have negative six-month returns.